口腔颌面部血管畸形微创治疗的应用与研究

The research and application of minimally invasive treatment of oral and maxillofacial vascular malformation

目的探讨口腔颌面部血管畸形微创治疗对口腔颌面部血管畸形患者治疗过程中的临床疗效。方法收集100例口腔颌面部血管畸形患者,随机分为观察组和对照组,各50例。对照组患者使用常规手术方法进行治疗,观察组根据患者的实际情况使用超选择性动脉内栓塞术、在彩色多普勒超声引导下的平阳霉素注射微创治疗以及平阳霉素联合微创治疗等进行治疗,观察两组患者在治疗后的疗效以及并发症发生率。结果两组患者在经过治疗后均有所好转,但观察组患者的治疗总有效率(98%)明显优于对照组患者的治疗总有效率(80%),同时观察组患者的并发症发生率(4%)明显优于对照组患者的并发症发生率(12%),差异有统计学意义(P<0.05)。结论在对口腔颌面部血管畸形患者进行治疗的过程中,使用微创手术治疗的方法效果更佳,并发症发生率更低,在临床治疗口腔颌面部血管畸形患者的过程中值得推广应用。

Objective To study the effect of minimally invasive treatment of oral and maxillofacial vascular malformations in the clinical efficacy of oral and maxillofacial vascular malformation patients during treatment.Methods The collection of 100 cases of oral and maxillofacial vascular malformation patients, randomly divided into observation group and control group, each of 50 cases. Patients in the control group using conventionaloperation method of treatment, the observation group patients according to the actual situation of patients treated with super selective intraarterial embolization, in color Doppler ultrasound guided minimally invasive treatment of Pingyang mycin injection and Pingyang mycin combined with minimally invasive treatment methodfor treatment, observation of curative effect of two groups of patients after treatment, complication rate.Results Two groups of patients improved after treatment for both, but the observation of patients in the treatment group the total effective rate （98%） was significantly better than the control patients in the treatment groupthe total efficiency （80%）, while the patients in the observation group the incidence of complications （4%） was significantly better than the control group of patients the incidence of complications （12%）, which was statistically significant differences （P〈0.05）o Conclusion In the patients with oral and maxillofacial vascular malformations in the course of treatment, the better effectusing minimally invasive operation method of treatment, complication rate is lower, it is worthy of promotion and application in clinical treatment of oral and maxillofacial vascular malformations in patients with.